$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Assessment of Loiasis and Outcomes of Ivermectin Masstreatment in Ijebu-North, Nigeria 원문보기

The Korean journal of parasitology, v.49 no.2 = no.150, 2011년, pp.153 - 159  

Hassan, A.A. (Department of Zoology, University of Ibadan) ,  Akinsanya, B. (Department of Zoology, University of Lagos) ,  lyase, N. (Department of Zoology, University of Ibadan) ,  Owagboriaye, F.O. (Department of Plant Science and Applied Zoology, Olabisi Onabanjo University)

Abstract ▼ AI-Helper 아이콘AI-Helper

A total of 286 individuals from 3 selected communities (Areedi-Aje, Ipakodo/Ojokodo, and Ijebu-Igbo) of Ijebu-North, southwestern Nigeria were examined for Loa loa microfilaremia using finger prick blood smear, between December 2008 and March 2009. Rapid assessment procedure for loiasis (RAPLOA) was...

주제어

#Loa loa   #microfilaremia   #ivermectin   #adverse reaction   #Nigeria  

AI 본문요약
AI-Helper 아이콘 AI-Helper

* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.

가설 설정

  • A question of interest should be the peculiarity of the locality in terms of sociocultural attitudes and practices. The observations of the present study could only confirm the possibility of equal vector exposure both on the farmlands visited by males and females and temporary human se

    제안 방법

    • the study. The purpose and methods of the study was discussed at length with the different community heads and head of school, who all gave their informed consent be­ fore the individual villagers were approached. The school com­ munity at Ijebu-Igbo was ^sembled by the school authority; for proper information dissemination.

    대상 데이터

    • The people are mainly Ijebus (Ybrub^). The study involved 3 com­ munities; Ijebu-Igbo, Areedi-Ajc and Ipakodo/Ojokodo envi­ rons, which are 10, 17, and 13 km, respectively from Ago-Iwoye (Lat N 6° 56’ 46.92", Long E 3° 55' 55.09'} the state university town (Fig. 1). Human population estimate at the time of the study was approximately 1, 000, 500, and b000z respectively.
    • December 2008 and March 2009. A total of 286 partici­ pant were enrolled for the study; 187, 57/ and 42 from Ijebu- Igbo, Ipakodo area, and Areedi~Ajez respectively. Individual questionnaire, designed according to rapid assessment proce­ dure for loiasis (RAPLOA) guidelines [18], to elicit responses to establish the histoiy of eye worm and duration of eye worm episode (between 1-7 days) were administered with the help of an interpreter.

    이론/모형

    • Statis­ tical Package for Socia1 Science (SPSS) (version 10 package) was used to determine the relationship of rapid assessment of L loa indices with occurrence of adverse reactions following treatment with ivermectin. Percentage of people who had con­ firmed eye worm experience was determined for each locality.
    • The use of 1 sterile blood lancet per partidpant was ensured, and used lancets were disinfected and properly dis­ posed. Thick blood smears were made on the slide using stan­ dard procedures for Leishman's stain [19]. The slides were ex­ amined microscopically with x 10 objective.
본문요약 정보가 도움이 되었나요?

참고문헌 (36)

  1. 1 Kyari F Gudlavalleti MV Sivsubramaniam S Gilbert CE Abdull MM Entekume G Foster A Nigeria National Blindness and Visual Impairment Study Group Prevalence of blindness and visual impairment in Nigeria: the National Blindness and Visual Impairment Study Invest Ophthalmol Vis Sci 2009 50 2033 2039 19117917 

    상세보기

  2. 2 Ashaye AO Glaucoma blindness: facts, fancies and fables 12th Faculty of Ophthalmology Lecture, National Postgraduate Medical College of Nigeria 2010 48 

  3. 3 The Mectizan® Expert Committee The Mectizan®Donation Program Recommendations for the treatment of onchocerciasis with Mectizan® in areas co-endemic for onchocerciasis and loiasis 2004 

  4. 4 "A New Drug for River Blindness?" World Health Organization 2007 www.who.int/tdr/ir/moxidectin.pdf 

  5. 5 Ogunba EO Loiasis in Ijebu division, West Nigeria Trop Geogr Med 1971 23 194 200 5568543 

  6. 6 Ogunba EO Ecology of human loiasis in Nigeria Trans R Soc Trop Med Hyg 1972 66 743 748 4647646 

    상세보기

  7. 7 Oyerinde JP Odugbemi T Fagbenro-Beyioku AF Investigation of filarial worms of man in metropolitan Lagos Acta Trop 1988 45 191 192 2901210 

  8. 8 Agbolade OM Akinboye DO Loiasis and some haematological parameters in Ijebu-North area of Ogun State, Nigeria Bull Sci Ass Nig 2000 23 29 32 

  9. 9 Agbolade OM Akinboye DO Loa loa and Mansonella perstans infections in Ijebu-North, Western Nigeria; a Parasitological Study Jpn J Infect Dis 2001 54 108 110 11544400 

  10. 10 Agbolade OM Akinboye DO Ogunkolo OF Loa loa and Mansonella perstans : neglected human infections that need control in Nigeria Afr J Biotech 2005 4 1554 1558 

  11. 11 Adeoye GO Akinsanya B Otubanjo AO Ibidapo CA Afolabi T Okwuzu I Adejai EO Braide EEI Prevalence of loiasis in Ondo State, Nigeria, as assessed by the rapid assessment procedure for loiasis (RAPLOA) Ann Trop Med Parasitol 2008 102 215 227 18348776 

  12. 12 Chippaux JP Boussinesq M Gardon JN Gardon-Wendel N Ernould JC Severe adverse reaction risk during mass treatment with ivermectin in loiasis- endemic areas Parasitol Today 1996 12 448 450 15275280 

  13. 13 Gardon J Gardon-Wendel N Demanga-Ngangue Kamgno J Chippaux JP Boussinesq M Serious reactions after treatment of onchocerciasis with ivermectin in an endemic area for Loa loa infection Lancet 1997 350 18 22 9217715 

  14. 14 Boussinesq M Gardon J Gardon-Wendel N Kamgno P Ngoumou P Chippaux JP Three probable causes of Loa loa encephalopathy following ivermectin treatment for onchocersiasis Am J Trop Med Hyg 1998 58 461 469 9574793 

  15. 15 Kipp W Bamhuhiiga J Rubaale T Buttner DW Adverse reaction to ivermectin treatment in Simulium neavei - transmitted onchocersiasis Am J Trop Med Hyg 2003 69 621 623 14740878 

  16. 16 Oyibo WA Fagbenro-Beyioku AF Adverse reaction following annual ivermectin treatment of onchocerciasis in Nigeria Int J Infect Dis 2003 7 156 159 12839719 

  17. 17 World Health Organisation UNDP/World Bank/WHO TDR/IDE/CDDI/D3.1 Report of a multi-country study: the involvement of community-directed distributors of ivermectin in other health and development activities 2003 

  18. 18 World Health Organization Doc TDR/IDE/RAPLOA/021 Guidelines for Rapid Assessment of Loa loa 2002 Geneva WHO 

  19. 19 Brown BA Haematology: Principles and Procedures 1980 3rd ed England Lea and Febiger 

  20. 20 Orihel TC Ash LR Ramachandran CP Ottensen EA Bench Aids for the Diagnosis of Filarial Infections: Geneva World Health Organization 1997 

  21. 21 Ranque S Garcia A Boussinesq M Gardon NJ Kamgno J Chippaux JP Decreased prevalence and intensity of Loa loa infection in a community treated with ivermectin every three months for two years Trans R Soc Trop Med Hyg 1996 90 429 430 8882197 

    상세보기

  22. 22 Hodgkin C Molyneux DH Abiose A Philippon B Reich MR Remme JH Thylefors B Traore M Grepin K The future of onchocerciasis control in Africa PLOS Negl Trop Dis 2007 1 e74 17989787 

  23. 23 Pion SDS Demanou B Oudi N Boussinesq M Loiasis: the individual factors associated with the presence of microfilaremia Ann Trop Med Parasitol 2005 99 491 500 16004708 

  24. 24 Tropical Diseases Research News. Keynote Article. Loa loa : a new rapid assessment tool TDR News 2001 66 1 2 

  25. 25 Rapid Assessment Procedures for Loiasis World Health Organization 2001 www.who.int/tdr/cdpublicaions/pdf/raploa.pdf 

  26. 26 Anosike JC Onwuliri CO Studies on filariasis in Bauchi State, Nigeria: the prevalence of human filariasis in Darazo local governmentarea Appl Parasitol 1994 35 242 250 7812311 

  27. 27 Udonsi JK Filariasis in Igwun River Basin, Nigeria: an epidemiological and clinical study with a note on the vectors Ann Trop Med Parasitol 1988 82 75 82 3041931 

  28. 28 Ash LR Preferential susceptibility of male jirds ( Meriones unguiculatus ) to infection with Brugia pahangi J Parasitol 1971 57 777 780 5105963 

    상세보기

  29. 29 Pion SDS Gardon NJ Kamgno J Gardon-Wendel N Chippaux JP Boussinesq M Structure of the microfilarial reservoir of Loa loa in the human host and its implications for monitoring the programmes of community-directed treatment with ivermectin carried out in Africa Parasitology 2004 129 613 629 15552406 

    상세보기

  30. 30 Garcia A Abel L Cot M Ranque S Richard P Boussinesq M Chippaux JP Longitudinal survey of Loa loa filariasis in Southern Cameroon: long-term stability and factors influencing individual microfilarial status Am J Trop Med Hyg 1995 52 370 375 7741181 

  31. 31 Pinder M Duport A Egwag TG Identification of a surface antigen on Loa loa microfilaraemic state in man J Immunol 1988 141 2480 2486 3049808 

  32. 32 Martin-Prevel Y Cosnefroy J Tshipamba P Ngari P Chodakewitz JA Pinder M Tolerance and efficacy of single high-dose ivermectin for the treatment of loiasis Am J Trop Med Hyg 1993 48 186 192 8447521 

  33. 33 Burnham GM Adverse reactions to ivermectin treatment for onchocerciasis: results of a placebo-controlled, double-blind trial in malaria Trans R Soc Trop Med Hyg 1993 87 313 317 8236405 

  34. 34 Duong TH Kombila M Ferrer A Bureau P Gaxotte P Richard-Lenoble D Reduced Loa loa microfilaria count ten to twelve months after a single dose of ivermectin Trans R Soc Trop Med Hyg 1997 91 592 593 9463677 

    상세보기

  35. 35 Pinder M Loa loa -a neglected filaria Parasitol Today 1988 4 279 284 15463001 

    상세보기

  36. 36 Wahl G Georges AJ Current knowledge on the epidemiology, diagnosis, immunology and treatment of loiasis Trop Med Parasitol 1995 46 287 291 8826114 

관련 콘텐츠

원문 보기

원문 URL 링크

*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

저작권 관리 안내

문의처: helpdesk@kisti.re.kr전화: 080-969-4114

Copyright KISTI. All Rights Reserved.

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로